These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 8896538)

  • 41. Early impact of universal varicella vaccination on childhood varicella and herpes zoster hospitalizations in Brazil.
    Scotta MC; Paternina-de la Ossa R; Lumertz MS; Jones MH; Mattiello R; Pinto LA
    Vaccine; 2018 Jan; 36(2):280-284. PubMed ID: 29198917
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia.
    Carville KS; Riddell MA; Kelly HA
    Vaccine; 2010 Mar; 28(13):2532-8. PubMed ID: 20117265
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of universal vaccination on the epidemiology of varicella in Veneto, Italy.
    Pozza F; Piovesan C; Russo F; Bella A; Pezzotti P; Emberti Gialloreti L
    Vaccine; 2011 Nov; 29(51):9480-7. PubMed ID: 22015389
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Perspective on live varicella vaccine.
    Gershon AA; Katz SL
    J Infect Dis; 2008 Mar; 197 Suppl 2():S242-5. PubMed ID: 18419404
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Chickenpox and shingles: one virus, two diseases and current vaccination recommendations in Switzerland].
    Eckert N; Masserey Spicher V
    Ther Umsch; 2016; 73(5):247-52. PubMed ID: 27268447
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Varicella zoster vaccines.
    Creed R; Satyaprakash A; Ravanfar P
    Dermatol Ther; 2009; 22(2):143-9. PubMed ID: 19335725
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain.
    Sauerbrei A; Eichhorn U; Gawellek S; Egerer R; Schacke M; Wutzler P
    J Med Virol; 2003 Oct; 71(2):313-9. PubMed ID: 12938208
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Varicella in Icelandic children--epidemiology and complications].
    Thórarinsdóttir H; Löve A; Laxdal T; Gudnason T; Haraldsson A
    Laeknabladid; 2009 Feb; 95(2):113-8. PubMed ID: 19197109
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Varicella.
    Heininger U; Seward JF
    Lancet; 2006 Oct; 368(9544):1365-76. PubMed ID: 17046469
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Seroepidemiology of varicella-zoster virus in Bangladesh.
    Saha SK; Darmstadt GL; Hanif M; Khan R
    Ann Trop Paediatr; 2002 Dec; 22(4):341-5. PubMed ID: 12530284
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevention strategies: experience of varicella vaccination programmes.
    Patrick D
    Herpes; 2007 Sep; 14 Suppl 2():48-51. PubMed ID: 17939897
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009.
    Weinmann S; Chun C; Schmid DS; Roberts M; Vandermeer M; Riedlinger K; Bialek SR; Marin M
    J Infect Dis; 2013 Dec; 208(11):1859-68. PubMed ID: 23922376
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current and future effects of varicella and herpes zoster vaccination in Germany - Insights from a mathematical model in a country with universal varicella vaccination.
    Horn J; Karch A; Damm O; Kretzschmar ME; Siedler A; Ultsch B; Weidemann F; Wichmann O; Hengel H; Greiner W; Mikolajczyk RT
    Hum Vaccin Immunother; 2016 Jul; 12(7):1766-76. PubMed ID: 26835890
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of varicella-zoster antibodies in pregnant women in Catalonia (Spain). Rationale for varicella vaccination of women of childbearing age.
    Plans P; Costa J; Espuñes J; Plasència A; Salleras L
    BJOG; 2007 Sep; 114(9):1122-7. PubMed ID: 17666097
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Declining incidence of chickenpox in the absence of universal childhood immunisation.
    Lowe GL; Salmon RL; Thomas DR; Evans MR
    Arch Dis Child; 2004 Oct; 89(10):966-9. PubMed ID: 15383443
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Live attenuated varicella vaccine use in immunocompromised children and adults.
    Gershon AA; Steinberg SP; Gelb L
    Pediatrics; 1986 Oct; 78(4 Pt 2):757-62. PubMed ID: 3020495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A seroepidemiological study of Varicella-Zoster virus in Taipei City.
    Lin YJ; Huang LM; Lee CY; Chih TW; Lee PL; Chang LY; Hsu CM
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(1):11-5. PubMed ID: 8936004
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term effectiveness of varicella vaccine: a 14-Year, prospective cohort study.
    Baxter R; Ray P; Tran TN; Black S; Shinefield HR; Coplan PM; Lewis E; Fireman B; Saddier P
    Pediatrics; 2013 May; 131(5):e1389-96. PubMed ID: 23545380
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Loss of vaccine-induced immunity to varicella over time.
    Chaves SS; Gargiullo P; Zhang JX; Civen R; Guris D; Mascola L; Seward JF
    N Engl J Med; 2007 Mar; 356(11):1121-9. PubMed ID: 17360990
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Varicella vaccine: the American experience.
    Gershon AA; LaRussa P; Hardy I; Steinberg S; Silverstein S
    J Infect Dis; 1992 Aug; 166 Suppl 1():S63-8. PubMed ID: 1320652
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.